Clinical Trial Update: Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating modulation of the nNOS system in Becker Muscular Dystrophy has completed, assessing cardiac, muscular, and cognitive function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Becker Muscular Dystrophy | Phase 2 | Status: COMPLETED